- Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023
- Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update
- Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference
- Kuros Biosciences Receives US FDA 510K Clearance for MagnetOs Granules for Interbody Use and Regulatory Clearance of MagnetOs Granules and MagnetOs Putty in New Zealand
- Kuros Biosciences Announces Three Advancements Related to its MagnetOsTM Portfolio Including Impressive Fusion Data from MAXA Prospective Randomized Clinical Trial and Two 510(k) Clearances from FDA
More ▼
Key statistics
On Thursday, Kuros Biosciences AG (CSBTF:PKL) closed at 6.30, -12.50% below its 52-week high of 7.20, set on Feb 21, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.65 |
---|---|
High | 6.65 |
Low | 6.30 |
Bid | -- |
Offer | -- |
Previous close | 6.25 |
Average volume | 9.94k |
---|---|
Shares outstanding | 36.84m |
Free float | 23.85m |
P/E (TTM) | -- |
Market cap | 223.24m CHF |
EPS (TTM) | -0.3697 CHF |
Data delayed at least 15 minutes, as of Mar 28 2024 14:33 BST.
More ▼